Givaudan | GIVN - Loan Capital


Givaudan reported CHF4.19B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Air Liquide EUR 11.06B 1.39B Dec/2025
Akzo Nobel EUR 4.76B 1.09B Mar/2026
Anheuser-Busch USD 70.35B 118M Dec/2025
Arkema EUR 3.81B 6.6M Mar/2026
Associated British Foods GBP 3.14B 164M Dec/2025
BASF EUR 18.48B 447M Dec/2025
Bayer EUR 30.68B 1.15B Mar/2026
Beiersdorf EUR 117M 15M Dec/2025
British American Tobacco GBP 31.71B 196M Dec/2025
Covestro EUR 1.67B 408M Dec/2025
Croda International GBP 650.9M 22.1M Dec/2024
Danone EUR 10.07B 501M Dec/2025
Diageo GBP 20.9B 675M Dec/2025
Fresenius EUR 9.22B 1.58B Dec/2025
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Givaudan CHF 4.19B 448M Dec/2025
Heineken EUR 16.19B 2.7B Dec/2025
Henkel EUR 1.38B 627M Dec/2025
International Flavors Fragrances USD 4.74B 1000K Mar/2026
Johnson Matthey GBP 1.35B 2M Jun/2026
Kerry EUR 2.48B 8.2M Dec/2024
Lonza CHF 3.88B 323M Dec/2025
L'Oréal EUR 9.43B 3.25B Dec/2025
Merck EUR 10.8B 72M Mar/2026
Nestle CHF 46.25B 742M Dec/2025
Pernod Ricard EUR 11.93B 1.15B Dec/2025
Reckitt Benckiser GBP 7.24B 590M Dec/2024
SGS CHF 3.11B 380M Dec/2024
Sika AG CHF 4.13B 1.4B Dec/2025
Solvay EUR 1.83B 8M Mar/2026
Tate & Lyle GBP 1.27B 141M Jun/2026
Umicore EUR 2.24B 10M Dec/2025
Victrex GBP 37.1M 7.5M Jun/2026